9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Retail prescription drug spending in the National Health Accounts.

      1
      Health affairs (Project Hope)

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Recent rapid spending growth for retail drugs has largely arisen from increased use of new drugs, rather than from increasing prices of existing drugs. A sizable shift in the payment from consumers to third parties has also contributed to faster growth. Strategies such as negotiating for rebates and using tiered copayments have sought to slow spending growth but simultaneously have complicated the estimation of spending in the National Health Accounts (NHA). NHA estimates show that retail pharmaceuticals' share of health spending is not much different than it was in 1960, although its share of gross domestic product (GDP) has tripled.

          Related collections

          Author and article information

          Journal
          Health Aff (Millwood)
          Health affairs (Project Hope)
          0278-2715
          0278-2715
          March 9 2004
          : 23
          : 1
          Affiliations
          [1 ] National Health Statistics Group, Office of the Actuary, Centers for Medicare and Medicaid Services in Baltimore, Maryland, USA.
          Article
          10.1377/hlthaff.23.1.160
          15002638
          927615da-45a5-49a3-909e-5c0ad7991a28
          History

          Comments

          Comment on this article